Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print RSS Feed

Breaking News

Related Searches:
Financial Report: Wyeth 3Q08

October 22, 2008
Wyeth 3Q Revenues: $5.8 billion (+5%) 3Q Earnings: $1.1 billion (flat) YTD Revenues: $17.5 billion (+5%) YTD Earnings: $3.5 billion (-4%) Comments: Pharmaceutical sales in the quarter were $4.9 billion (+5%) driven by Enbrel, Prevnar a…  Read More »
Lilly, Amylin Enter Exenatide Supply Pact

October 22, 2008
Amylin Pharmaceuticals and Lilly have entered into a product supply agreement for exenatide once weekly, a compound under development to treat type 2 diabetes. Under terms of the agreement, Amylin will receive an initial cash payment of $125 million…  Read More »
Financial Report: Pfizer 3Q08

October 21, 2008
Pfizer 3Q Revenues: $12.0 billion (flat) 3Q Earnings: $2.3 billion (earnings were $761 million in 3Q07) YTD Revenues: $36.0 billion (+1%) YTD Earnings: $7.8 billion (+45%) Comments: Pharmaceutical revenues in the quarter were $11.0 bil…  Read More »
Financial Report: Schering-Plough 3Q

October 21, 2008
Schering-Plough 3Q Revenues: $4.6 billion (+63%)   3Q Earnings: $589.0 million (-21%) YTD Revenues: $14.2 billion (+58%) YTD Earnings: $1.3 billion (-29%) Comments: Pharmaceutical sales were $3.5 billion in the quarter (+54%) driv…  Read More »
Financial Report: Biogen Idec 3Q

October 21, 2008
Biogen Idec 3Q Revenues: $1.1 billion (+38%) 3Q Earnings: $207 million (+74%) YTD Revenues: $3.0 billion (+33%) YTD Earnings: $576.5 million (+32%) Comments: Tysabri sales recorded by Biogen, based on its collaboration with Elan, were…  Read More »
Azopharma to Provide Microdosing Services

October 21, 2008
Azopharma Product Development Group has entered the microdosing market and will provide services to synthesize material open to microdose studies as well as formulate and administer microdoses in a clinical setting, and analyze samples.   …  Read More »
Laureate, Tolerx Enter Manufacturing Pact

October 21, 2008
Laureate Pharma has entered into a cGMP contract manufacturing agreement with Tolerx, Inc. to produce Tolerx's humanized anti-GITR antibody known as TRX518, which is currently in development for cancer and chronic viral indications. Details of the ag…  Read More »
Althea Technologies

October 21, 2008
Shabbir Anik, Ph.D. will join Althea Technologies as president and chief executive officer. Dr. Anik will lead the company's expansion of its product development, clinical trial and commercial manufacturing services.      &n…  Read More »
Pfizer, UCB Form New Technology Company

October 20, 2008
Pfizer and UCB have formed a new technology company, Cyclofluidic, established with the goal of accelerating the drug discovery process by allowing researchers to test a broader range of potential new drug in less time. The UK Government&rs…  Read More »
Novartis Restructures

October 20, 2008
Novartis AG is restructuring the management of three of four business units, with plans to cut 550 marketing jobs in an effort to save $80 million annually starting in 2010, according to Joerg Reinhardt, head of the vaccines unit and chief opera…  Read More »
Financial Report: Novartis 3Q

October 20, 2008
Novartis 3Q Revenues: $10.7 billion (+12%) 3Q Earnings: $2.1 billion (+32%) YTD Revenues: $31.4 billion (+12%) YTD Earnings: $6.7 billion (+19%) Comments: Pharmaceutical sales were $6.7 billion in the quarter, up 14…  Read More »
Financial Report: Gilead Sciences 3Q

October 17, 2008
Gilead Sciences 3Q Revenues: $1.4 billion (+30%) 3Q Earnings: $504 million (+27%) YTD Revenues: $3.9 billion (+25%)   YTD Earnings: $1.4 billion (+19%) Comments: The company achieved record revenues in the quarter. Growth was drive…  Read More »
Valeant GSK Complete Retigabine Collaboration

October 17, 2008
Valeant Pharmaceuticals International has concluded its exclusive worldwide collaboration agreement with GlaxoSmithKline for retigabine, an investigational drug for the treatment of adult epilepsy patients with refractory partial onset seizures. Unde…  Read More »
Catalent's Brussels Facility Gets First FDA Product Approval

October 17, 2008
Catalent Pharma Solutions received notice that the FDA has approved the sale of a prescription product manufactured at its recently opened pre-filled syringe facility in Brussels, Belgium. Syringes from the Brussels facility will likely be dispensed…  Read More »
Financial Report: Abbott 3Q08

October 16, 2008
Abbott 3Q Revenues: $7.5 billion (+18%) 3Q Earnings: $1.1 billion (+51%) YTD Revenues: $22.0 billion (+15%) YTD Earnings: $3.3 billion (+39%) Comments: Worldwide pharmaceutical sales were $4.1 billion in the quarter (+17%), driven by g…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: